Konica Minolta (4902) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
13 Jun, 2025Executive summary
Revenue increased 7.4% year-over-year to ¥286.2 billion, with all five business segments posting growth, aided by favorable FOREX and strong performance in performance materials, industrial print, DW-DX, and Precision Medicine.
Business contribution profit improved to ¥1.6 billion from a ¥4.1 billion loss, and operating loss narrowed to ¥0.3 billion, reflecting higher gross profit and deficit reduction in non-focused businesses.
Net loss attributable to owners improved to ¥3.4 billion from ¥5.6 billion loss year-over-year; basic EPS was -¥6.98.
Revenue growth was strongest in Asia (ex-China) at 21%, followed by China (17%), North America (8%), and Europe (4%), while Japan declined 1%.
Segment reclassification implemented to align with the Medium-term Business Plan, focusing on business selection and concentration.
Financial highlights
Gross profit rose 13% year-over-year to ¥126.4 billion; gross profit ratio improved by about 2 points to 44.2%.
SG&A expenses increased 8% to ¥124.8 billion, mainly due to FOREX and higher personnel costs.
Free cash outflow improved to ¥8.2 billion from ¥10.8 billion a year ago, supported by business transfers.
Equity ratio attributable to owners increased to 39.9% from 38.9% at March 31, 2024.
Cash and cash equivalents at period-end were ¥111.7 billion, down ¥17.8 billion from March 31, 2024.
Outlook and guidance
FY2024 earnings forecast remains unchanged: revenue ¥1,160.0 billion, business contribution profit ¥40.0 billion (+54%), operating profit ¥13.0 billion (-50%), and profit attributable to owners at break-even.
Exchange rate assumptions for the year: ¥140/USD and ¥150/EUR; sensitivity analysis provided for major currencies.
Focus continues on business selection, concentration, and global structural reforms.
Latest events from Konica Minolta
- Operating profit rebounded sharply and outlook was raised, despite lower revenue.4902
Q3 20265 Feb 2026 - Operating profit surged to ¥23.0B despite 8% revenue drop, led by cost reforms and segment gains.4902
Q2 20265 Nov 2025 - Profit and margins improved despite revenue drop, cost cuts, and tariff and currency headwinds.4902
Q1 202631 Jul 2025 - Business profit up, operating loss on restructuring; Ambry sale to yield ¥41B gain.4902
Q2 202513 Jun 2025 - Impairments drove a sharp loss, but profit recovery and higher dividends are forecast.4902
Q4 20256 Jun 2025 - Profit growth outweighed by impairment losses and restructuring, with outlook unchanged.4902
Q3 20255 Jun 2025